A citation-based method for searching scientific literature

S Dinneen, A Alzaid, D Turk, R Rizza. Diabetologia 1995
Times Cited: 137







List of co-cited articles
1563 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.
P Shah, A Vella, A Basu, R Basu, W F Schwenk, R A Rizza. J Clin Endocrinol Metab 2000
298
43



Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.
R W Gelling, X Q Du, D S Dichmann, J Romer, H Huang, L Cui, S Obici, B Tang, J J Holst, C Fledelius,[...]. Proc Natl Acad Sci U S A 2003
374
22

Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice.
Young Lee, May-Yun Wang, Xiu Quan Du, Maureen J Charron, Roger H Unger. Diabetes 2011
224
21


Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.
Kyle W Sloop, Julia Xiao-Chun Cao, Angela M Siesky, Hong Yan Zhang, Diane M Bodenmiller, Amy L Cox, Steven J Jacobs, Julie S Moyers, Rebecca A Owens, Aaron D Showalter,[...]. J Clin Invest 2004
156
18

Impact of lack of suppression of glucagon on glucose tolerance in humans.
P Shah, A Basu, R Basu, R Rizza. Am J Physiol 1999
97
18




Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.
W A Müller, G R Faloona, E Aguilar-Parada, R H Unger. N Engl J Med 1970
578
17

Glucagon and regulation of glucose metabolism.
Guoqiang Jiang, Bei B Zhang. Am J Physiol Endocrinol Metab 2003
463
16


Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.
Jesper Gromada, Isobel Franklin, Claes B Wollheim. Endocr Rev 2007
394
16

The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
16


Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice.
Yin Liang, Melville C Osborne, Brett P Monia, Sanjay Bhanot, William A Gaarde, Chantal Reed, Pengxiang She, Thomas L Jetton, Keith T Demarest. Diabetes 2004
145
15

Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
Michael A Nauck, Markus M Heimesaat, Kai Behle, Jens J Holst, Markus S Nauck, Robert Ritzel, Michael Hüfner, Wolff H Schmiegel. J Clin Endocrinol Metab 2002
401
14

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
T Vilsbøll, T Krarup, J Sonne, S Madsbad, A Vølund, A G Juul, J J Holst. J Clin Endocrinol Metab 2003
363
14





Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system.
Elaine Xu, Mohan Kumar, Yi Zhang, William Ju, Toshiyuki Obata, Nina Zhang, Shiying Liu, Anna Wendt, Shaoping Deng, Yousuke Ebina,[...]. Cell Metab 2006
173
13

Studies of pancreatic alpha cell function in normal and diabetic subjects.
R H Unger, E Aguilar-Parada, W A Müller, A M Eisentraut. J Clin Invest 1970
918
13


Glycemic control in mice with targeted disruption of the glucagon receptor gene.
Janice C Parker, Kim M Andrews, Melanie R Allen, Jeffrey L Stock, John D McNeish. Biochem Biophys Res Commun 2002
105
12

Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia.
J J Meier, B Gallwitz, N Siepmann, J J Holst, C F Deacon, W E Schmidt, M A Nauck. Diabetologia 2003
213
12



One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.
Kristine B Degn, Claus B Juhl, Jeppe Sturis, Grethe Jakobsen, Birgitte Brock, Visvanathan Chandramouli, Joergen Rungby, Bernard R Landau, Ole Schmitz. Diabetes 2004
330
11


Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist.
D G Johnson, C U Goebel, V J Hruby, M D Bregman, D Trivedi. Science 1982
128
11


The unique cytoarchitecture of human pancreatic islets has implications for islet cell function.
Over Cabrera, Dora M Berman, Norma S Kenyon, Camillo Ricordi, Per-Olof Berggren, Alejandro Caicedo. Proc Natl Acad Sci U S A 2006
717
11

A K ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans.
Patrick E MacDonald, Yang Zhang De Marinis, Reshma Ramracheya, Albert Salehi, Xiaosong Ma, Paul R V Johnson, Roger Cox, Lena Eliasson, Patrik Rorsman. PLoS Biol 2007
159
11

Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.
S L Conarello, G Jiang, J Mu, Z Li, J Woods, E Zycband, J Ronan, F Liu, R Sinha Roy, L Zhu,[...]. Diabetologia 2007
149
11


Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.
Ivan Quesada, Eva Tudurí, Cristina Ripoll, Angel Nadal. J Endocrinol 2008
220
11


A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes.
Steve Edelman, Satish Garg, Juan Frias, David Maggs, Yan Wang, Bei Zhang, Susan Strobel, Karen Lutz, Orville Kolterman. Diabetes Care 2006
99
11

A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.
Fred Whitehouse, Davida F Kruger, Mark Fineman, Larry Shen, James A Ruggles, David G Maggs, Christian Weyer, Orville G Kolterman. Diabetes Care 2002
185
10

Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes.
Bo Ahrén, Mona Landin-Olsson, Per-Anders Jansson, Maria Svensson, David Holmes, Anja Schweizer. J Clin Endocrinol Metab 2004
517
10


Regulation of alpha-cell function by the beta-cell in isolated human and rat islets deprived of glucose: the "switch-off" hypothesis.
Kristine M Hope, Phuong Oanh T Tran, Huarong Zhou, Elizabeth Oseid, Eric Leroy, R Paul Robertson. Diabetes 2004
85
11

Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release.
Isobel Franklin, Jesper Gromada, Asllan Gjinovci, Sten Theander, Claes B Wollheim. Diabetes 2005
220
10

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
10

Dose-response for glucagonostatic effect of amylin in rats.
B R Gedulin, T J Rink, A A Young. Metabolism 1997
135
9

The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus.
B Nyholm, L Orskov, K Y Hove, C H Gravholt, N Møller, K G Alberti, C Moyses, O Kolterman, O Schmitz. Metabolism 1999
83
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.